DocGo Inc. Payments for Commissions
DocGo Inc. (DCGO) reported Payments for Commissions of $323.74 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForCommissions · last filed 2025-11-10
- DocGo Inc. payments for commissions for the quarter ending 2025-09-30 was $323.74K, a 21.49% decline year-over-year.
- DocGo Inc. payments for commissions for the quarter ending 2025-06-30 was $287.80K, a 21.72% decline year-over-year.
- DocGo Inc. payments for commissions for the quarter ending 2025-03-31 was $279.75K, a 10.46% increase year-over-year.
- DocGo Inc. payments for commissions for the quarter ending 2024-09-30 was $412.35K, a 101.44% increase year-over-year.
- DocGo Inc. payments for commissions for fiscal 2021 was $155.09K, a 82.78% increase from fiscal 2020.
- DocGo Inc. payments for commissions for fiscal 2020 was $84.85K.
| Period end | Payments for Commissions 3 month | Payments for Commissions 6 month | Payments for Commissions 9 month | Payments for Commissions 12 month |
|---|---|---|---|---|
| 2025-09-30 | $323.74K 10-Q · filed 2025-11-10 | $611.53K derived: sum of 2 quarters · filed 2025-11-10 | $891.28K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $287.80K 10-Q · filed 2025-08-07 | $567.54K 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | $279.75K 10-Q · filed 2025-05-08 | |||
| 2024-09-30 | $412.35K 10-Q · filed 2025-11-10 | $780.02K derived: sum of 2 quarters · filed 2025-11-10 | $1.03M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $367.67K 10-Q · filed 2025-08-07 | $620.92K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $253.25K 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $204.70K 10-Q · filed 2024-11-07 | $331.30K derived: sum of 2 quarters · filed 2024-11-07 | $674.97K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $126.60K 10-Q · filed 2024-08-07 | $470.27K 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $234.23K 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | $261.19K 10-Q · filed 2023-11-06 | $261.19K 10-Q · filed 2022-11-08 | $704.59K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $234.25K 10-Q · filed 2023-08-08 | $443.41K 10-Q · filed 2023-08-08 | ||
| 2021-12-31 | -$321.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$262.22K derived: sum of 2 quarters · filed 2022-11-08 | -$135.13K derived: sum of 3 quarters · filed 2022-11-08 | $155.09K 10-K · filed 2022-03-15 |
| 2021-09-30 | $58.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-08 | $186.07K 10-Q · filed 2022-11-08 | $476.29K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $127.09K 10-Q · filed 2022-08-09 | $290.22K 10-Q · filed 2022-08-09 | ||
| 2020-12-31 | $84.85K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |